Source: Rttnews
Creative Medical Completes ADAPT Trial Enrollment; Advances Olastrocel; Stock Up
Creative Medical (CELZ) completed enrollment and treatment across all cohorts of its ADAPT trial evaluating Olastrocel in chronic lower back pain. Earlier data showed meaningful improvements in pain and function with a favorable safety profile.
Key Points
- Creative Medical (CELZ) completed enrollment and treatment across all cohorts of its ADAPT trial evaluating Olastrocel in chronic lower back pain.
- Earlier data showed meaningful improvements in pain and function with a favorable safety profile.
Published: August 20, 2026 1:47 pm
Source: Rttnews